Benchmark research studies12/10/2023 Mark and his team plan to continue to do more studies covering a wide range of indications in all age groups. Benchmark Research’s range of the types of studies being conducted is impressive and is one of the reasons why they are so successful. Even so, they have diversified themselves to conduct a range of studies other than vaccines. Today, vaccine studies are highly sought after. One of the biggest achievements is that Benchmark Research entered the realm of vaccines when they were deemed less desirable in the industry and has successfully built the foundation of the research they do on vaccines. All our sites we participated have been recognized by Pfizer for our high enrollment in these trials,” says Mark. “We were the first site network visited by Operation Warp Speed Leadership to plan the logistics of executing 30k subjects COVID-19 vaccine efficacy studies in the United States. Recently, Benchmark Research participated in the COVID-19 vaccine trials and continues to participate in these ongoing studies. The first and only site network to deploy a Virtual/Remote CRC model to support OWS Vaccine.Operation Warp Speed Leadership visited the first site network to plan the logistics of executing 30k subject COVID 19 Vaccine Efficacy Studies in the US.Industry Excellence more times than any other site or site network.ěenchmark has been recognized for excellence by the World Vaccine Congress Vaccine.ěenchmark has a well-established relationship with all the big vaccine companies and the CROs performing vaccine studies on behalf of their clients, large and small.Ěverage leadership tenure is ten years (Senior Leadership/site directors). Investigator (COO) and a recognized vaccine expert with >35 years of vaccine development experience from the site, pharma, and CRO organizations.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |